Human Immunodeficiency Virus Clinical Trials in Atlanta, Georgia
3 recruitingAtlanta, Georgia
Showing 1–3 of 3 trials
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 4
Low Dose Naltrexone for Pain in Patients With HIV
Human Immunodeficiency VirusChronic Neuropathic Pain
Emory University60 enrolled3 locationsNCT05537935
Recruiting
Phase 2
Baricitinib for Reduction of HIV - CNS
Human Immunodeficiency Virus
William Tyor95 enrolled2 locationsNCT05452564